APA (7th ed.) Citation

P, S., M, T., TDL, N., B, S., H, B., R, v. M., . . . S, P. (2017). Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer. Cancer chemotherapy and pharmacology, 80(5), 1005. https://doi.org/10.1007/s00280-017-3446-y

Chicago Style (17th ed.) Citation

P, Samaras, Tusup M, Nguyen-Kim TDL, Seifert B, Bachmann H, von Moos R, Knuth A, and Pascolo S. "Phase I Study of a Chloroquine-gemcitabine Combination in Patients with Metastatic or Unresectable Pancreatic Cancer." Cancer Chemotherapy and Pharmacology 80, no. 5 (2017): 1005. https://doi.org/10.1007/s00280-017-3446-y.

MLA (9th ed.) Citation

P, Samaras, et al. "Phase I Study of a Chloroquine-gemcitabine Combination in Patients with Metastatic or Unresectable Pancreatic Cancer." Cancer Chemotherapy and Pharmacology, vol. 80, no. 5, 2017, p. 1005, https://doi.org/10.1007/s00280-017-3446-y.